ALGS vs. TSLA
ALGS (Aligos Therapeutics, Inc.) and TSLA (Tesla, Inc.) are both stocks. ALGS operates in Biotechnology (Healthcare), while TSLA operates in Auto Manufacturers (Consumer Cyclical). Over the past 5 years, ALGS returned -57.85%/yr vs 11.09%/yr for TSLA. At a 0.20 correlation, their price movements are largely independent.
Performance
ALGS vs. TSLA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ALGS achieves a -43.35% return, which is significantly lower than TSLA's -17.82% return.
ALGS
- 1D
- -8.01%
- 1M
- -0.00%
- 6M
- -33.50%
- YTD
- -43.35%
- 1Y
- -42.36%
- 3Y*
- -39.53%
- 5Y*
- -57.85%
- 10Y*
- —
- ALL TIME*
- -53.52%
TSLA
- 1D
- -2.96%
- 1M
- -7.72%
- 6M
- -15.53%
- YTD
- -17.82%
- 1Y
- 12.11%
- 3Y*
- 12.43%
- 5Y*
- 11.09%
- 10Y*
- 37.94%
- ALL TIME*
- 42.40%
ALGS vs. TSLA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
ALGS Aligos Therapeutics, Inc. | -43.35% | -76.61% | 140.00% | -30.32% | -91.97% | -57.07% | 58.91% |
TSLA Tesla, Inc. | -17.82% | 11.36% | 62.52% | 101.72% | -65.03% | 49.76% | 57.21% |
Correlation
The correlation between ALGS and TSLA is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Oct 16, 2020 | 0.20 |
Fundamentals
ALGS:
$32.67M
TSLA:
$1.39T
ALGS:
-$8.70
TSLA:
$1.10
ALGS:
29.25
TSLA:
13.34
ALGS:
1.73
TSLA:
15.55
ALGS:
$1.88M
TSLA:
$97.88B
ALGS:
$1.36M
TSLA:
$18.66B
ALGS:
-$94.69M
TSLA:
$10.48B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ALGS vs. TSLA — Risk / Return Rank
ALGS
TSLA
ALGS vs. TSLA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aligos Therapeutics, Inc. (ALGS) and Tesla, Inc. (TSLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ALGS | TSLA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.80 | ||
| Sortino ratioReturn per unit of downside risk | -1.10 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 1.08 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | -0.67 | 0.41 | -1.08 |
| Martin ratioReturn relative to average drawdown | -1.10 | 0.87 | -1.97 |
Loading charts...
Drawdowns
ALGS vs. TSLA - Drawdown Comparison
The maximum ALGS drawdown since its inception was -99.54%, which is greater than TSLA's maximum drawdown of -73.63%. Use the drawdown chart below to compare losses from any high point for ALGS and TSLA.
Loading charts...
Drawdown Indicators
| ALGS | TSLA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.54% | -73.63% | -25.91% |
Max Drawdown (1Y)Largest decline over 1 year | -63.07% | -29.93% | -33.14% |
Max Drawdown (3Y)Largest decline over 3 years | -91.25% | -53.77% | -37.48% |
Max Drawdown (5Y)Largest decline over 5 years | -99.10% | -73.63% | -25.47% |
Max Drawdown (10Y)Largest decline over 10 years | — | -73.63% | — |
Current DrawdownCurrent decline from peak | -99.40% | -24.56% | -74.84% |
Average DrawdownAverage peak-to-trough decline | -84.37% | -22.69% | -61.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 38.59% | 13.93% | +24.66% |
Volatility
ALGS vs. TSLA - Volatility Comparison
Aligos Therapeutics, Inc. (ALGS) has a higher volatility of 21.06% compared to Tesla, Inc. (TSLA) at 16.93%. This indicates that ALGS's price experiences larger fluctuations and is considered to be riskier than TSLA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ALGS | TSLA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.06% | 16.93% | +4.13% |
Volatility (6M)Calculated over the trailing 6-month period | 54.17% | 31.31% | +22.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.71% | 44.73% | +35.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 99.31% | 59.31% | +40.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 99.89% | 59.26% | +40.63% |
Dividends
ALGS vs. TSLA - Dividend Comparison
Neither ALGS nor TSLA has paid dividends to shareholders.
Financials
ALGS vs. TSLA - Financials Comparison
This section allows you to compare key financial metrics between Aligos Therapeutics, Inc. and Tesla, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ALGS and TSLA have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ALGS has higher volatility (21.06%) compared to TSLA (16.93%). In terms of maximum drawdown, ALGS dropped -99.54% vs TSLA's -73.63%.
TSLA currently has the higher Sharpe Ratio (0.27 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ALGS and TSLA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer